Enzyme Acquires Myso Finance, Expanding Investment Opportunities
Enzyme has announced its acquisition of Myso Finance, a move set to broaden investment options for users. This partnership will introduce new opportunities such as covered calls.
- Myso's v3 update is imminent, promising further innovations
- The acquisition aligns with Enzyme's goal of improving on-chain asset management
- It follows Enzyme's recent focus on simplifying processes and removing intermediaries
This development comes after Enzyme's founder, Mona El Isa, discussed the future of on-chain asset management with Real Vision, highlighting:
- Simplified creation of incentivized liquidity vaults
- Automation of financial processes
- Increased transparency and self-custody
For more details on the acquisition and its implications, interested parties can refer to the official announcement.